U.S. markets closed

PURE Bioscience, Inc. (PURE)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4099-0.0053 (-1.29%)
At close: 3:53PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.4153
Open0.4105
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3900 - 0.4105
52 Week Range0.2700 - 1.8500
Volume47,285
Avg. Volume37,966
Market Cap35.753M
Beta (5Y Monthly)0.02
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • PURE BIOSCIENCE
    Analyst Report: Marvell Technology, Inc.Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
All
News
Press Releases